SPX3,640.70-78.34 -2.11%
DIA292.22-4.51 -1.52%
IXIC10,737.51-314.13 -2.84%

BRIEF-Sparingvision Raises €75 Million Series B To Continue Building World-Leading Portfolio Of Genomic Medicines For Ocular Diseases

BRIEF-Sparingvision Raises €75 Million Series B To Continue Building World-Leading Portfolio Of Genomic Medicines For Ocular Diseases

Reuters · 09/14/2022 07:11
BRIEF-Sparingvision Raises €75 Million Series B To Continue Building World-Leading Portfolio Of Genomic Medicines For Ocular Diseases

-

  • SPARINGVISION RAISES €75 MILLION SERIES B TO CONTINUE BUILDING WORLD-LEADING PORTFOLIO OF GENOMIC MEDICINES FOR OCULAR DISEASES

  • SPARINGVISION - ROUND WAS CO-LED BY JEITO CAPITAL AND UPMC ENTERPRISES

Source text for Eikon: ID:


((Reuters.Briefs@thomsonreuters.com;))